NCT07332351 2026-03-13
TRIFECTA
University of Washington
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT07424287 2026-02-20
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Not yet recruiting
NCT06822010 2025-11-14
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
Rutgers, The State University of New Jersey
Phase 2 Not yet recruiting
NCT06829823 2025-10-16
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer
ImmunityBio, Inc.
Phase 2 Not yet recruiting
NCT07189793 2025-09-24
OHAI-NMIBC-01
First Affiliated Hospital of Wenzhou Medical University
Phase 2 Not yet recruiting
NCT07184021 2025-09-19
No Acronym
Assiut University
Phase 2 Not yet recruiting
NCT07064863 2025-07-17
BCG-TIME
Queen's University
Phase 1/2 Not yet recruiting
NCT06623162 2024-10-04
SASAN-SPARING
Fundación de investigación HM
Phase 2 Not yet recruiting
NCT06591650 2024-09-19
Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer
Fudan University
Phase 2 Not yet recruiting
NCT06327932 2024-03-25
HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Not yet recruiting
NCT06227065 2024-01-26
POLO
University of Bern
Phase 2 Not yet recruiting